What do you do with the antiplatelet agents in patients with drug eluting stents who then receive a mechanical valve?

Interactive Cardiovascular and Thoracic Surgery

Volumn 15, Issue 1, 2012, Pages 115-121

  Rossi, Michele ^a   Serraino, Giuseppe Filiberto ^a   Spadafora, Andrea ^a   Renzulli, Attilio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Antiplatelet agents; Drug eluting stent; Mechanical prosthesis; Oral anticoagulation; Percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DALTEPARIN; HISTAMINE H2 RECEPTOR ANTAGONIST; PACLITAXEL; PROTON PUMP INHIBITOR; RAPAMYCIN;

AORTA VALVE STENOSIS; ARTICLE; BARE METAL STENT; BLEEDING; CARBOMEDICS PROSTHETIC HEART VALVE; CLINICAL PROTOCOL; CORONARY ARTERY OBSTRUCTION; DRUG ELUTING STENT; ELECTIVE SURGERY; EVIDENCE BASED MEDICINE; HEART VALVE BIOPROSTHESIS; HEART VALVE PROSTHESIS; HIGH RISK PATIENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; LOW DRUG DOSE; MEDICAL DECISION MAKING; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSTHETIC VALVE THROMBOSIS; RISK ASSESSMENT; SAINT JUDE HEART VALVE PROSTHESIS; STENT THROMBOSIS; SYSTEMATIC REVIEW; THERAPY DELAY; TREATMENT DURATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANGIOPLASTY, BALLOON, CORONARY; ANIMALS; ANTICOAGULANTS; ASPIRIN; BENCHMARKING; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; DRUG-ELUTING STENTS; EVIDENCE-BASED MEDICINE; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PLATELET AGGREGATION INHIBITORS; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; SIROLIMUS; THROMBOSIS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84863446638     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivs104     Document Type: Article

References (16)

1. Dunning J, Prendergast B, Mackway-Jones K. Towards evidence-based medicine in cardiothoracic surgery: best BETS. Interact CardioVasc Thorac Surg 2003;2:405-9.
2. Salem DN, Stein PD, Al-Ahmad A, Bussey HI, Horstkotte D, Miller N et al. Antithrombotic therapy in valvular heart disease-native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:172S-696S.
3. Grines CL, Bonow RO, Casey DE Jr, Gardner TJ, Lockhart PB, Moliterno DJ et al. American Heart Association; American College of Cardiology; Society for Cardiovascular Angiography and Interventions; American College of Surgeons; American Dental Association; American College of Physicians. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 2007;115: 813-8.
4. King SB 3rd, Smith SC Jr, Hirshfeld JW Jr, Jacobs AK, Morrison DA, Williams DO et al.; 2005 WRITING COMMITTEE MEMBERS. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation 2008;117:261-95.
5. Cannegieter SC, Rosendaal FR, Briët E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994;89:635-41.
6. McKellar SH, Thompson JL 3rd, Garcia-Rinaldi RF, Macdonald RJ, Sundt TM 3rd, Schaff HV. Short-and long-term efficacy of aspirin and clopidogrel for thromboprophylaxis for mechanical heart valves: an in vivo study in swine. J Thorac Cardiovasc Surg 2008;136:908-14.
7. Schlitt A, Hauroeder B, Buerke M, Peetz D, Victor A, Hundt F et al. Effects of combined therapy of clopidogrel and aspirin in preventing thrombus formation on mechanical heart valves in an ex vivo rabbit model. Thromb Res 2002;107:39-43.
8. Schlitt A, von Bardeleben RS, Ehrlich A, Eimermacher A, Peetz D, Dahm M et al. Clopidogrel and aspirin in the prevention of thromboembolic complications after mechanical aortic valve replacement (CAPTA). Thromb Res 2003;109:131-5.
9. García-Rinaldi R, Carro-Pagán C, Schaff HV, McKellar SH, Thompson JL3rdQuiñones J et al. Initial experience with dual antiplatelet thromboprophylaxis using clopidogrel and aspirin in patients with mechanical aortic prostheses. J Heart Valve Dis 2009;18:617-25.
10. Ait Mokhtar O, Bonello L, Armero S, Sbragia P, Paganelli F. Early and late outcomes of clopidogrel and coumadin combination for patients on oral anticoagulants undergoing coronary stenting. Cardiovasc Revasc Med 2010;11:159-62.
11. Nguyen MC, Lim YL, Walton A, Lefkovits J, Agnelli G, Goodman SG et al. GRACE Investigators. Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent. Eur Heart J 2007;28: 1717-22.
12. Khurram Z, Chou E, Minutello R, Bergman G, Parikh M, Naidu S et al. Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding. J Invasive Cardiol 2006;18:162-4.
13. DeEugenio D, Kolman L, DeCaro M, Andrel J, Chervoneva I, Duong P et al. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy. Pharmacotherapy 2007;27:691-6.
14. Sarafoff N, Ndrepepa G, Mehilli J, Dörrler K, Schulz S, Iijima R et al. Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation. J Intern Med 2008;264:472-80.
15. Lip GY, Huber K, Andreotti F, Arnesen H, Airaksinen KJ, Cuisset T et al. European Society of Cardiology Working Group on Thrombosis. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting. Thromb Haemost 2010; 103:13-28.
16. Sambola A, Ferreira-González I, Angel J, Alfonso F, Maristany J, Rodríguez O et al. Therapeutic strategies after coronary stenting in chronically anticoagulated patients: the MUSICA study. Heart 2009;95: 1483-8.